The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study

BACKGROUND: Irritable bowel syndrome (IBS) is one of the world's most common gastrointestinal (GI) disorders, and current treatments do not meet patients' demands. This study aimed to investigate melatonin's therapeutic effects on IBS score, GI symptoms, quality of life, and sleep par...

Descripción completa

Detalles Bibliográficos
Autores principales: Faghih Dinevari, Masood, Jafarzadeh, Farzaneh, Jabbaripour Sarmadian, Amirreza, Abbasian, Samaneh, Nikniaz, Zeinab, Riazi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131443/
https://www.ncbi.nlm.nih.gov/pubmed/37098505
http://dx.doi.org/10.1186/s12876-023-02760-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131443/
https://www.ncbi.nlm.nih.gov/pubmed/37098505
http://dx.doi.org/10.1186/s12876-023-02760-0

Ejemplares similares